Ownership history in Integrated Wealth Concepts LLC · 11 quarters on record
This page tracks every 13F SEC filing in which Integrated Wealth Concepts LLC reported a position in Galectin Therapeutics Inc (GALT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 10,000 | -52 | -0.5% | 0.00% | $42K | $4.24 |
| 2025 Q2 | ADDED | 10,052 | +42 | +0.4% | 0.00% | $21K | $2.11 |
| 2025 Q1 | ADDED | 10,010 | +8 | +0.1% | 0.00% | $12K | $1.22 |
| 2024 Q4 | ADDED | 10,002 | +2 | +0.0% | 0.00% | $13K | $1.29 |
| 2024 Q3 | UNCHANGED | 10,000 | — | 0% | 0.00% | $28K | $2.75 |
| 2024 Q2 | UNCHANGED | 10,000 | — | 0% | 0.00% | $23K | $2.26 |
| 2024 Q1 | UNCHANGED | 10,000 | — | 0% | 0.00% | $24K | $2.39 |
| 2023 Q4 | UNCHANGED | 10,000 | — | 0% | 0.00% | $17K | $1.66 |
| 2023 Q3 | UNCHANGED | 10,000 | — | 0% | 0.00% | $19K | $1.92 |
| 2023 Q2 | UNCHANGED | 10,000 | — | 0% | 0.00% | $14K | $1.44 |
As of 2025 Q4 — sorted by position size